Cerium Pharmaceuticals, Inc.
PrivateLast Round
Seed
Aug 6, 2026
Total Funding Raised
$19M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cerium Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of medicines for rare and orphan diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerium Pharmaceuticals, Inc. Comparables
Compare Cerium Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asahi Kasei | 72% | |
| ANI Pharmaceuticals Inc | 70% | |
| Mironid | 69% | |
Cerium Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 6, 2026 | ||||
| Series B | Nov 9, 2021 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 6, 2026
$750K raised in Seed Round.
- May 14, 2026
Monthly visitors increased 61% MoM, reaching 2.7K.
Cerium Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cerium Pharmaceuticals, Inc.'s valuation, stock price, and market status.